Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309018023> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4309018023 endingPage "vii274" @default.
- W4309018023 startingPage "vii274" @default.
- W4309018023 abstract "Abstract OBJECTIVE The median age of onset for glioblastoma (GBM; IDHwt) is 68-70 years. Age is a strong prognostic factor for GBM patient outcomes such that overall survival in older adults is less than their younger counterparts – even after adjustment for MGMT promoter methylation status. Aging is associated with increased levels of senescence in the brain. Several age-related neurological disorders have been shown to improve with senolytic treatments. Here, we explored the effects and therapeutic neutralization of syngeneic brain tumors on increasing senescence levels in the extratumoral brain (ie. outside of the brain tumor) of young and old mice. METHODS General RNA-sequencing, as well as single-cell (sc) RNA-sequencing was performed on extratumoral tissue from young (8-12 weeks) and older adult (80-90 weeks) C57BL/6 mice with or without GL261 and key markers were validated with RT-PCR. The combined effects of the senolytics, dasatinib and quercetin, with radiation, anti-PD-1 mAb, and IDO enzyme inhibitor treatment, was also investigated. RESULTS General- and sc-RNA sequencing revealed a distinct gene expression profile in the extratumoral brain of older mice with syngeneic GL261 as compared to all other groups. RT-PCR results confirmed that the brain tumor increased gene expression for senescence levels, p53, and NFkB signaling in the older adult extratumoral brain. Expression of the senescence marker p16INK4A was primarily localized to oligodendrocyte progenitor cells in the older adult brain. The combinatorial treatment of senolytics with RT, anti-PD-1 mAb, and IDO enzyme inhibitor led to a synergistic survival benefit in older adult mice with GL261 as compared to the treatment with senolytics, or immunotherapy, alone. CONCLUSIONS The data suggest that the extratumoral brain may be responsible in-part for the poorer outcomes of older adults with GBM and that treatment approaches that target senescent cells may provide clinical benefit." @default.
- W4309018023 created "2022-11-20" @default.
- W4309018023 creator A5014536195 @default.
- W4309018023 creator A5019501470 @default.
- W4309018023 creator A5023153659 @default.
- W4309018023 creator A5023866306 @default.
- W4309018023 creator A5034490707 @default.
- W4309018023 creator A5040284400 @default.
- W4309018023 creator A5049572543 @default.
- W4309018023 creator A5050603971 @default.
- W4309018023 creator A5060733211 @default.
- W4309018023 creator A5067476970 @default.
- W4309018023 creator A5074786388 @default.
- W4309018023 creator A5074788911 @default.
- W4309018023 creator A5074800269 @default.
- W4309018023 creator A5078785815 @default.
- W4309018023 creator A5082027834 @default.
- W4309018023 date "2022-11-01" @default.
- W4309018023 modified "2023-10-16" @default.
- W4309018023 title "TMIC-15. AGE-RELATED MARKERS FOR SENESCENCE INCREASE IN THE OLDER ADULT EXTRATUMORAL MOUSE BRAIN DUE TO GLIOBLASTOMA" @default.
- W4309018023 doi "https://doi.org/10.1093/neuonc/noac209.1059" @default.
- W4309018023 hasPublicationYear "2022" @default.
- W4309018023 type Work @default.
- W4309018023 citedByCount "0" @default.
- W4309018023 crossrefType "journal-article" @default.
- W4309018023 hasAuthorship W4309018023A5014536195 @default.
- W4309018023 hasAuthorship W4309018023A5019501470 @default.
- W4309018023 hasAuthorship W4309018023A5023153659 @default.
- W4309018023 hasAuthorship W4309018023A5023866306 @default.
- W4309018023 hasAuthorship W4309018023A5034490707 @default.
- W4309018023 hasAuthorship W4309018023A5040284400 @default.
- W4309018023 hasAuthorship W4309018023A5049572543 @default.
- W4309018023 hasAuthorship W4309018023A5050603971 @default.
- W4309018023 hasAuthorship W4309018023A5060733211 @default.
- W4309018023 hasAuthorship W4309018023A5067476970 @default.
- W4309018023 hasAuthorship W4309018023A5074786388 @default.
- W4309018023 hasAuthorship W4309018023A5074788911 @default.
- W4309018023 hasAuthorship W4309018023A5074800269 @default.
- W4309018023 hasAuthorship W4309018023A5078785815 @default.
- W4309018023 hasAuthorship W4309018023A5082027834 @default.
- W4309018023 hasBestOaLocation W43090180231 @default.
- W4309018023 hasConcept C126322002 @default.
- W4309018023 hasConcept C2779134260 @default.
- W4309018023 hasConcept C2779695026 @default.
- W4309018023 hasConcept C502942594 @default.
- W4309018023 hasConcept C522857546 @default.
- W4309018023 hasConcept C71924100 @default.
- W4309018023 hasConcept C86803240 @default.
- W4309018023 hasConceptScore W4309018023C126322002 @default.
- W4309018023 hasConceptScore W4309018023C2779134260 @default.
- W4309018023 hasConceptScore W4309018023C2779695026 @default.
- W4309018023 hasConceptScore W4309018023C502942594 @default.
- W4309018023 hasConceptScore W4309018023C522857546 @default.
- W4309018023 hasConceptScore W4309018023C71924100 @default.
- W4309018023 hasConceptScore W4309018023C86803240 @default.
- W4309018023 hasIssue "Supplement_7" @default.
- W4309018023 hasLocation W43090180231 @default.
- W4309018023 hasOpenAccess W4309018023 @default.
- W4309018023 hasPrimaryLocation W43090180231 @default.
- W4309018023 hasRelatedWork W1997032085 @default.
- W4309018023 hasRelatedWork W1997795769 @default.
- W4309018023 hasRelatedWork W2012601130 @default.
- W4309018023 hasRelatedWork W2019906715 @default.
- W4309018023 hasRelatedWork W2059425897 @default.
- W4309018023 hasRelatedWork W2342908730 @default.
- W4309018023 hasRelatedWork W2511201656 @default.
- W4309018023 hasRelatedWork W2547248593 @default.
- W4309018023 hasRelatedWork W3016295646 @default.
- W4309018023 hasRelatedWork W4298080702 @default.
- W4309018023 hasVolume "24" @default.
- W4309018023 isParatext "false" @default.
- W4309018023 isRetracted "false" @default.
- W4309018023 workType "article" @default.